CION Cancer Clinics
What the RPLND specimen shows | CION Cancer Clinics
After an RPLND, the removed tissue is examined under a microscope. The report usually shows dead tissue and scar, called necrosis or fibrosis; a slow-growing tumour called teratoma; or living cancer. A large lump can hold more than one. Each result leads to a different next step, from follow-up scans to a talk about more treatment. This page explains the words on the report and what your team weighs. CION Cancer Clinics’ surgical oncologists in Hyderabad can talk this through with you.
On this page
- What can the laboratory find in an RPLND specimen?
- What do necrosis, teratoma and living cancer each mean?
- What happens to the tissue after the operation?
- Which words on the report need explaining?
- How does the result change what happens next?
- What do families often get wrong about the specimen report?
- Common questions about the RPLND specimen report
The short answer
What can the laboratory find in an RPLND specimen?
After an RPLND, the tissue that was removed is examined under a microscope, and the report usually shows one of three things. It may be dead tissue and scar, it may be a slow-growing tumour called teratoma, or it may be living cancer. Often a large lump holds more than one of these.
Why a scan could not tell you this beforehand
A CT or PET-CT shows that a lump is there and how big it is. It cannot see what the lump is made of. Scar, teratoma and active cancer can look almost the same on a scan, and blood markers stay normal with both scar and teratoma. That is one of the main reasons the lump is removed rather than guessed at.
Why this report matters so much
The specimen report is the point where your team stops working from pictures and starts working from tissue. It is the document they will use to decide whether you need nothing more than follow-up scans, or whether further treatment should be discussed. Bring a family member to the appointment where it is explained, because the details are easy to lose when you are anxious.
Your report may use the word histopathology. It simply means the study of tissue under a microscope.Reading the result
What do necrosis, teratoma and living cancer each mean?
These three words cover most specimen reports after chemotherapy. Each one leads to a different conversation with your team.
Necrosis or fibrosis
Necrosis means dead tissue. Fibrosis means scar. Together they tell you the chemotherapy killed the cancer cells in that lump, and what was left behind was the shell.
What usually follows
- Regular follow-up scans and blood markers
- No further treatment in most cases
Teratoma
A tumour type that chemotherapy does not shrink and blood markers do not show. It grows slowly, can press on nearby organs, and very rarely changes into a different kind of cancer.
What usually follows
- Complete removal is itself the treatment
- Close follow-up rather than more chemotherapy
Living cancer
Also called viable germ cell tumour. Some active cancer cells survived the chemotherapy. This is the least common result after chemotherapy, and the one your team will discuss most carefully.
Whether more chemotherapy is offered depends on how much was found and whether it was fully removed.A mixture
Large lumps often contain scar in one part and teratoma or living cancer in another. The report then lists each part, and the plan is built around the most active part found.
Not sure whether this applies to you?
Ask an oncologistBehind the scenes
What happens to the tissue after the operation?
Labelled in theatre
The surgeon separates the tissue by area, such as the left side, the right side and the region between the two large blood vessels. Each part goes in its own labelled pot, so the laboratory knows exactly where every finding came from.
Examined by eye and measured
The pathologist, the doctor who reads tissue, weighs and measures each piece, looks for lymph nodes and describes any lump. A large lump is cut into many slices so no part is missed.
Thin slices on glass slides
Small pieces are set in wax, sliced very thinly and stained. This preparation is what takes the time. Extra stains are sometimes added to confirm the exact tumour type.
The written report
It usually reaches your surgeon in a week or two. Large lumps after chemotherapy can take longer, because more of the tissue has to be sampled. Your team reads it before your appointment.
On your report
Which words on the report need explaining?
- Lymph nodes examined
- How many small glands the laboratory found in the tissue. It shows how thoroughly the area was cleared.
- Lymph nodes involved
- How many of those glands held cancer. Along with the size of the largest deposit, this sets the N category on your staging.
- Extranodal extension
- Cancer that has broken through the outer wall of a node into the fat around it. Your team takes this into account when planning.
- Embryonal carcinoma, yolk sac tumour, seminoma
- Names for particular types of germ cell cancer. The report names each type found, because they behave differently.
- Margin
- The edge of the tissue removed. A clear margin means no tumour was seen at the cut edge.
- Mature or immature teratoma
- Describes how developed the teratoma cells look. Both are treated by removing them completely.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Teratoma is one reason surgeons remove a leftover lump even when the blood markers are normal. Teratoma does not release those markers, so a normal blood test cannot rule it out.
After the report
How does the result change what happens next?
The report does not make the decision on its own. Your team reads it alongside your original testicular report, your scans before and after chemotherapy, and your blood markers. The same finding can lead to a different plan in two different men.
After an RPLND done without chemotherapy first
This is called a primary RPLND. If the nodes are clear, follow-up is usually all that is needed. If cancer is found, the number and size of the affected nodes guide whether the team suggests a short course of chemotherapy or careful watching. That is a shared decision, and you are entitled to ask why one is being favoured.
After an RPLND done following chemotherapy
Scar or teratoma alone usually means follow-up rather than more treatment. Living cancer opens a discussion about further chemotherapy. The team weighs how much was found, whether it was all removed and which drugs you have already had.
Questions worth taking to the appointment
Ask what was found in each area. Ask whether everything visible was removed. Ask how often you will be scanned from now on, and who to call if a new symptom appears.
This page cannot tell you what your own result means for you. Only the team holding your full records can.Commonly believed
What do families often get wrong about the specimen report?
It was not. Nobody could know the lump was only scar until it was examined. Finding dead tissue is the result everyone hopes for, and it means you can move to follow-up with far more certainty than a scan could give.
Teratoma is slow, but left in place it can keep growing, press on the kidneys or bowel, and rarely turn into a more aggressive cancer. Chemotherapy does not treat it. Surgery is the treatment.
Not so. Germ cell cancers often still respond to further treatment. The finding changes the plan. It does not end it. Ask your team what options they are weighing and why.
Markers are useful, but teratoma and some living cancer do not raise them. A normal blood test before surgery tells you nothing certain about what the lump contains.
Questions we are asked
Common questions about the RPLND specimen report
How long does the RPLND pathology report take?
Usually a week or two after the operation. A large lump removed after chemotherapy can take longer, because the laboratory has to slice and sample much more tissue to be sure nothing is missed. If you are still waiting beyond what you were told, call your surgeon's office and ask where the report stands.
What does necrosis on the report mean?
It means dead tissue. In a lump removed after chemotherapy, it tells you the treatment killed the cancer cells that were there. It is usually followed by regular scans and blood tests rather than more treatment. Your team will confirm what it means in your own case.
Is teratoma cancer?
It is a type of germ cell tumour, and it is taken seriously even though it grows slowly. It does not respond to chemotherapy and does not raise blood markers. It can keep growing and rarely change into a different cancer, which is why complete removal matters. After full removal, follow-up is the usual plan.
If living cancer is found, will I need more chemotherapy?
Possibly, but not automatically. Your team looks at how much living cancer was found, whether it was all removed, and which chemotherapy you have already had. Some men are offered more treatment and some are watched closely. Ask them to explain which way they are leaning, and why.
Why were so many lymph nodes removed if only a few had cancer?
The surgeon clears a mapped area, not just the nodes that looked abnormal. Small deposits of cancer cannot be seen by eye or on a scan. Removing the whole area lets the laboratory check every node, which gives a more reliable picture of what is going on.
Can I get a second opinion on the slides?
Yes. The wax blocks and slides are stored by the laboratory, and you can ask for them to be sent to another pathologist. This is common with rarer tumour types. Ask your surgeon's team how to request them, and keep a copy of the written report with you.
Does a clear report mean the cancer will not come back?
No report can promise that. A clear result is good news and usually means you move to follow-up. The follow-up scans and blood tests exist because a small risk of return remains. Keep every appointment, even when you feel completely well.
Who should explain the report to us?
Your surgeon or oncologist, ideally after the team has discussed it together. Reading the report alone at home often leads to fear over words written for another doctor. If you have it before your appointment, write down your questions and bring them with you.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Testicular Cancer Treatment (PDQ) - Patient Version
- American Cancer Society — Surgery for Testicular Cancer
- Cancer Research UK — Testicular cancer: treatment
- Macmillan Cancer Support — Testicular cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Have an RPLND report you do not understand?
Send it to us or call the helpline. A surgical oncologist will go through it with you and help you prepare questions for your team. One helpline serves every CION centre.